News & Press Releases

Bloomberg Law published an article written by Cross-Border Asset Recovery Practice Chair Kevin Ainsworth about Amaplat Mauritius Ltd. v. Zimbabwe Mining Dev. Corp., where the DC Circuit dismissed a bid to recognize a foreign court judgment confirming a foreign arbitration award against a sovereign. The court held that US federal courts lack jurisdiction under the Foreign Sovereign Immunities Act when such claims are filed after the three-year deadline, and rejected the petitioners’ implied waiver arguments.

World Intellectual Property Review and Life Sciences Intellectual Property Review featured insights from Intellectual Property Division Chair Michael Renaud about Masimo’s decision to sue US Customs and Border Protection (CBP), the latest development in its legal battle with Apple. The article notes that it’s uncommon for a patent owner to sue CBP, which is backed by the US International Trade Commission (ITC), and that the results of this action may determine whether patent owners will still be able to rely on exclusion orders as enforcement tools in the future.

Benchmark Litigation has recognized six Mintz Members as leading litigation attorneys in its 2025 40 & Under List. This recognition identifies “the best and brightest litigators” ages 40 and under.

Mintz Members Daniel Bleck, Poonam Patidar, and Vanessa Yen have been named to BTI Consulting Group’s 2025 Client Service All-Star list. This recognition celebrates attorneys who consistently deliver the highest tier of client service.

Mintz Intellectual Property Chair Michael Renaud has been named a Go-To Lawyer by Massachusetts Lawyers Weekly in its 2025 Intellectual Property Law edition. This award recognizes senior attorneys with proven legal acumen, successful results, strong peer referrals, and a reputation for innovative thinking.

Health Law Practice Chair and Health Care Enforcement Defense Practice Co-chair Karen Lovitch shared insights with 360Dx on recent letters sent by legislators to the Centers for Medicare and Medicaid Services (CMS), which request a delay in upcoming price cuts and reporting requirements related to the Protecting Access to Medicare Act (PAMA). Karen notes that the requests appear to fall within CMS's regulatory authority and align with past congressional actions aimed at maintaining stability in lab reimbursement policy.